NCT07401667

Brief Summary

Aim and Objectives: The study aimed to evaluate the effectiveness of titanium inserts for interdental papilla reconstruction, comparing it with the Han and Takei technique using subepithelial connective tissue grafts. The objectives included assessing the black triangle height, papilla height and papilla presence index (PPI) at baseline, 1 month and 3 months post operatively along with the evaluation of Early Wound Healing Score (EHS) during the first week of post operative healing period. Patients and Methods: This single-blind randomized clinical trial included systemically healthy individuals aged 18-35 years with Nordland and Tarnow's Class I-III papillary loss. A total of 18 participants were randomly assigned to either test group or control group. Clinical parameters were measured pre- and post-operatively at specified intervals. Both groups received standard presurgical care and postoperative follow-up. The surgical protocol for the test group involved titanium insert placement in the interdental bone, while the control group received a connective tissue graft using the Han and Takei method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 21, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 10, 2026

Completed
Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

1.6 years

First QC Date

August 30, 2025

Last Update Submit

February 3, 2026

Conditions

Keywords

Connective tissue graftstitanium insertsblack trianglepapilla heightpapilla reconstruction

Outcome Measures

Primary Outcomes (3)

  • Interdental papilla height

    To be measured from base of the papilla (a line joining the two adjacent teeth gingival zenith) to the tip of the papilla. Measured with UNC-15 probe.

    3 MONTHS

  • Black triangle height

    Measurement from the tip of the interdental papilla to the apical-most point of the contact point. Measured using a digital vernier caliper.

    3 MONTHS

  • Papilla presence index (PPI)

    given by Cardaropoli et al

    3 MONTHS

Secondary Outcomes (1)

  • Early Wound Healing Score (EHS)

    1 WEEK

Study Arms (2)

TITANIUM INSERTS FOR PAPILLA RECONSTRUCTION

EXPERIMENTAL
Device: TITANIUM INSERTS

SUB-EPITHELIAL CONNECTIVE TISSUE GRAFT FOR PAPILLA RECONSTRUCTION USING HAN & TAKEI TECHNIQUE

ACTIVE COMPARATOR
Procedure: CONNECTIVE TISSUE GRAFT

Interventions

The titanium papillary insert2 is composed of a pyramidal- shaped polished titanium core; it has a height of 2 to 3 mm and a base that is 3 mm bucco-lingually and 1 mm in the mesio-distal dimension. It also has mesial and distal concavities to allow for the emergence of the papilla. It is fitted into the bone between two adjacent teeth by means of a self-taping screw extension that is 0.8 mm in diameter and 5 mm in length.

TITANIUM INSERTS FOR PAPILLA RECONSTRUCTION

CTG is widely used across a broad range of clinical indications in periodontal and peri-implant therapy. It is primarily indicated for the treatment of gingival recession, reduction of dentinal hypersensitivity, and correction of mucogingival deformities.

SUB-EPITHELIAL CONNECTIVE TISSUE GRAFT FOR PAPILLA RECONSTRUCTION USING HAN & TAKEI TECHNIQUE

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Systemically healthy male and female patients with a stable periodontal health of age 18-35 years.
  • Patients with Nordland and Tarnow's1 Class I, II, III interdental papillary loss at a single site and Gingival recession \< 2 mm on the facial aspect.
  • Patients presenting with adequate width of attached gingiva (2-3mm)
  • Having a thick gingival biotype (2 mm)

You may not qualify if:

  • Midline diastema patients
  • Medically compromised patients
  • Pregnant and lactating women
  • Heavy smokers,
  • Patient who underwent radiotherapy \& chemotherapy,
  • Patients with any bleeding or clotting disorders
  • Patients not willing to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Svs Institute of Dental Sciences

Mahbūbnagar, Telangana, 509001, India

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PROFESSOR AND HEAD OF DEPARTMENT

Study Record Dates

First Submitted

August 30, 2025

First Posted

February 10, 2026

Study Start

May 21, 2023

Primary Completion

December 21, 2024

Study Completion

May 21, 2025

Last Updated

February 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Locations